tiprankstipranks
Trending News
More News >
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR

Compare Monopar Therapeutics Inc (MNPR) vs. Competitors

Compare
571 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Monopar Therapeutics Inc
$66.89
$397.15M
23.81%
11 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$1.68
$106.43M
-1.99
-63.00%
6 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$8.05
$449.13M
-5.31
69.64%
3 Buy
1 Hold
0 Sell
Strong Buy
Verastem
$6.30
$511.42M
15.67%
4 Buy
0 Hold
0 Sell
Strong Buy
Mereo Biopharma Group Plc
$0.42
$65.23M
-1.56
-87.03%
6 Buy
2 Hold
0 Sell
Strong Buy
Silence Therapeutics
$4.84
$203.11M
-2.57
-23.35%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNPR
Monopar Therapeutics Inc
59.43
10.66
21.86%
CRDF
Cardiff Oncology
1.58
-3.04
-65.80%
VNDA
Vanda
7.60
3.07
67.77%
VSTM
Verastem
6.79
0.84
14.12%
MREO
Mereo Biopharma Group Plc
0.41
-2.80
-87.23%
SLN
Silence Therapeutics
4.30
-1.75
-28.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts